rss
J Neurol Neurosurg Psychiatry 79:1236-1244 doi:10.1136/jnnp.2007.134825
  • Research paper

Regional grey matter atrophy in clinically isolated syndromes at presentation

  1. R G Henry1,2,
  2. M Shieh1,
  3. D T Okuda3,
  4. A Evangelista3,
  5. M L Gorno-Tempini3,
  6. D Pelletier3
  1. 1
    Department of Radiology, University of California at San Francisco, California, USA
  2. 2
    Graduate Group in Bioengineering, University of California at Berkeley & San Francisco, California, USA
  3. 3
    Department of Neurology, University of California at San Francisco, California, USA
  1. Roland G Henry, Center for Molecular and Functional Imaging, 185 Berry Street, Suite 350, San Francisco, CA 94107, USA; Roland.Henry{at}radiology.ucsf.edu
  • Received 13 September 2007
  • Revised 26 March 2008
  • Accepted 3 April 2008
  • Published Online First 9 May 2008

Abstract

Background: The presence and degree of neuronal degeneration already existing in patients at their initial presentation with a clinically isolated syndrome suggestive of multiple sclerosis (CIS) is unclear, and whole brain or whole normalised grey matter analyses have not demonstrated significant atrophy in CIS cohorts at clinical presentation. Voxel-based analyses allow detection of regional atrophy throughout the brain and, therefore, may be sensitive to regional atrophy in CIS patients, and these changes may correspond with clinical disability.

Methods: This study used a modified voxel-based morphometry (VBM) method to correct for lesion effects to analyse regional atrophy and perform voxel-wise correlations between volume and clinical metrics in 41 untreated CIS patients at presentation compared with 49 healthy controls.

Results: The results confirmed that there was no significant difference in whole normalised grey matter volume between CIS and controls, whereas VBM showed significant areas of bilateral thalamic, hypothalamic, putamen and caudate atrophy. Voxel-wise correlations with clinical measures showed that cerebellar volumes correlated with clinical cerebellar function, nine-hole peg test scores and the Multiple Sclerosis Functional Composite (MSFC) score, and that the MSFC score was also correlated with putamen volume. Lastly, T1 lesion volumes were found to correlate with thalamic and hippocampal atrophy, suggesting a link between white matter lesions and grey matter degeneration at the earliest stages of multiple sclerosis.

Conclusions: Atrophy is present in CIS patients at presentations, particularly in the thalamus, and other deep grey matter structures. Furthermore, the correlations with clinical metrics suggest the importance of this atrophy to clinical status and the correlation with T1 lesion load suggests a possible role of Wallerian degeneration.

Footnotes

  • Competing interests: None declared.

Podcasts
Visit the full archive of podcasts for JNNP here >>

Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JNNP.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article